Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intracoronary physiology-guided percutaneous coronary intervention in patients with diabetes.
Scarsini R, Tebaldi M, Rubino F, Sgreva S, Vescovo G, Barbierato M, Vicerè A, Galante D, Mammone C, Lunardi M, Tavella D, Pesarini G, Campo G, Leone AM, Ribichini FL. Scarsini R, et al. Among authors: tebaldi m. Clin Res Cardiol. 2023 Sep;112(9):1331-1342. doi: 10.1007/s00392-023-02243-y. Epub 2023 Jun 20. Clin Res Cardiol. 2023. PMID: 37338598 Free PMC article.
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study.
Campo G, Valgimigli M, Gemmati D, Percoco G, Catozzi L, Frangione A, Federici F, Ferrari F, Tebaldi M, Luccarelli S, Parrinello G, Ferrari R. Campo G, et al. Among authors: tebaldi m. J Am Coll Cardiol. 2007 Sep 18;50(12):1132-7. doi: 10.1016/j.jacc.2007.04.092. Epub 2007 Sep 4. J Am Coll Cardiol. 2007. PMID: 17868803 Free article.
Abciximab: a reappraisal of its use in coronary care.
Valgimigli M, Campo G, Tebaldi M, Carletti R, Arcozzi C, Ferrari R, Percoco G. Valgimigli M, et al. Among authors: tebaldi m. Biologics. 2008 Mar;2(1):29-39. doi: 10.2147/btt.s1374. Biologics. 2008. PMID: 19707425 Free PMC article.
Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials.
Valgimigli M, Biondi-Zoccai G, Tebaldi M, van't Hof AW, Campo G, Hamm C, ten Berg J, Bolognese L, Saia F, Danzi GB, Briguori C, Okmen E, King SB, Moliterno DJ, Topol EJ. Valgimigli M, et al. Among authors: tebaldi m. Eur Heart J. 2010 Jan;31(1):35-49. doi: 10.1093/eurheartj/ehp376. Epub 2009 Sep 14. Eur Heart J. 2010. PMID: 19755402 Review.
Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY).
Valgimigli M, Campo G, Percoco G, Monti M, Ferrari F, Tumscitz C, Zuffi A, Colombo F, Kubbajeh M, Cavazza C, Cangiano E, Tebaldi M, Minarelli M, Arcozzi C, Scalone A, Frangione A, Borghesi M, Marchesini J, Parrinello G, Ferrari R. Valgimigli M, et al. Among authors: tebaldi m. Am Heart J. 2010 Nov;160(5):804-11. doi: 10.1016/j.ahj.2010.07.034. Am Heart J. 2010. PMID: 21095265 Clinical Trial.
Genetic determinants of on-clopidogrel high platelet reactivity.
Campo G, Miccoli M, Tebaldi M, Marchesini J, Fileti L, Monti M, Valgimigli M, Ferrari R. Campo G, et al. Among authors: tebaldi m. Platelets. 2011;22(6):399-407. doi: 10.3109/09537104.2011.579648. Epub 2011 May 31. Platelets. 2011. PMID: 21627411 Review.
Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome.
Campo G, Parrinello G, Ferraresi P, Lunghi B, Tebaldi M, Miccoli M, Marchesini J, Bernardi F, Ferrari R, Valgimigli M. Campo G, et al. Among authors: tebaldi m. J Am Coll Cardiol. 2011 Jun 21;57(25):2474-83. doi: 10.1016/j.jacc.2010.12.047. J Am Coll Cardiol. 2011. PMID: 21679849 Free article.
Prasugrel versus tirofiban bolus with or without short post-bolus infusion with or without concomitant prasugrel administration in patients with myocardial infarction undergoing coronary stenting: the FABOLUS PRO (Facilitation through Aggrastat By drOpping or shortening Infusion Line in patients with ST-segment elevation myocardial infarction compared to or on top of PRasugrel given at loading dOse) trial.
Valgimigli M, Tebaldi M, Campo G, Gambetti S, Bristot L, Monti M, Parrinello G, Ferrari R; FABOLUS PRO Investigators. Valgimigli M, et al. Among authors: tebaldi m. JACC Cardiovasc Interv. 2012 Mar;5(3):268-77. doi: 10.1016/j.jcin.2012.01.006. JACC Cardiovasc Interv. 2012. PMID: 22440491 Free article. Clinical Trial.
175 results